Insights

Expanding Market Indications IlluminOss Medical's system is indicated for a broad range of fracture types across multiple anatomical sites in both the US and EU markets. This presents opportunities to target hospitals and clinics treating traumatic, pathological, and fragility fractures, especially those seeking minimally invasive solutions.

Strategic Growth Partnerships Recent collaborations with investors like HealthpointCapital highlight a focus on expanding regulatory approvals and market presence. Business development efforts can leverage these partnerships to pursue new anatomical indications and geographic markets, enhancing sales potential.

Focus on Trauma and Aging Populations The product launch targeting fragility fractures linked to aging populations indicates a growth niche. Sales strategies should emphasize the appeal of minimally invasive, patient-specific procedures suitable for elderly patients with complex fractures.

Technological Differentiation IlluminOss's proprietary light-curable polymer and minimally invasive intramedullary implant technology provide a unique value proposition. Promoting this innovative approach can attract orthopedic surgeons and hospitals seeking advanced, less invasive fracture repair options.

Revenue and Funding Opportunities With recent revenue estimates between 1 to 10 million dollars and strategic funding of five million dollars, the company is positioned for growth. Expanding sales efforts into new geographical regions or specialty centers could unlock further revenue streams and market share.

IlluminOss Medical Tech Stack

IlluminOss Medical uses 8 technology products and services including Facebook Pixel, Google Fonts API, Font Awesome, and more. Explore IlluminOss Medical's tech stack below.

  • Facebook Pixel
    Analytics
  • Google Fonts API
    Font Scripts
  • Font Awesome
    Font Scripts
  • Twemoji
    Font Scripts
  • PHP
    Programming Languages
  • X-XSS-Protection
    Security
  • Phusion Passenger
    Web Servers
  • Facebook
    Widgets

Media & News

IlluminOss Medical's Email Address Formats

IlluminOss Medical uses at least 1 format(s):
IlluminOss Medical Email FormatsExamplePercentage
FLast@illuminoss.comJDoe@illuminoss.com
83%
Last@illuminoss.comDoe@illuminoss.com
12%
FirstL@illuminoss.comJohnD@illuminoss.com
3%
First.Last@illuminoss.comJohn.Doe@illuminoss.com
2%

Frequently Asked Questions

What is IlluminOss Medical's phone number?

Minus sign iconPlus sign icon
You can contact IlluminOss Medical's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is IlluminOss Medical's official website and social media links?

Minus sign iconPlus sign icon
IlluminOss Medical's official website is illuminoss.com and has social profiles on LinkedInCrunchbase.

How much revenue does IlluminOss Medical generate?

Minus sign iconPlus sign icon
As of December 2025, IlluminOss Medical's annual revenue is estimated to be $2.4M.

What is IlluminOss Medical's SIC code NAICS code?

Minus sign iconPlus sign icon
IlluminOss Medical's SIC code is 3841 - Surgical and Medical Instruments and Apparatus NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does IlluminOss Medical have currently?

Minus sign iconPlus sign icon
As of December 2025, IlluminOss Medical has approximately 35 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technical Officer / Founder: R. R.Vice President Of Sales: W. I.Vp Regulatory Affairs And Quality Assurance: M. S.. Explore IlluminOss Medical's employee directory with LeadIQ.

What industry does IlluminOss Medical belong to?

Minus sign iconPlus sign icon
IlluminOss Medical operates in the Medical Equipment Manufacturing industry.

What technology does IlluminOss Medical use?

Minus sign iconPlus sign icon
IlluminOss Medical's tech stack includes Facebook PixelGoogle Fonts APIFont AwesomeTwemojiPHPX-XSS-ProtectionPhusion PassengerFacebook.

What is IlluminOss Medical's email format?

Minus sign iconPlus sign icon
IlluminOss Medical's email format typically follows the pattern of FLast@illuminoss.com. Find more IlluminOss Medical email formats with LeadIQ.

How much funding has IlluminOss Medical raised to date?

Minus sign iconPlus sign icon
As of December 2025, IlluminOss Medical has raised $5M in funding. The last funding round occurred on Feb 05, 2016 for $5M.

When was IlluminOss Medical founded?

Minus sign iconPlus sign icon
IlluminOss Medical was founded in 2007.

IlluminOss Medical

Medical Equipment ManufacturingRhode Island, United States11-50 Employees

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, the IlluminOss System. This minimally invasive technology allows for fracture stabilization through the use of patient specific intramedullary implants.

IlluminOss utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of fracture stabilization. 

US Indications: The IlluminOss System is indicated for use in skeletally mature patients in the treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, ulna, clavicle, pelvis, fibula, metacarpals, metatarsals, and phalanges. 

The IlluminOss System can also be used in conjunction with FDA-cleared fracture fixation systems to provide supplemental fixation in these anatomic sites. The IlluminOss System may be used in the femur and tibia to provide supplemental fixation to an anatomically appropriate FDA-cleared fracture fixation system.

EU Indications: The IlluminOss System is indicated for use in fracture alignment reduction. It provides stabilization for bone fractures using a minimally invasive technique in which the bone is not subjected to significant weight bearing forces. This IlluminOss procedure pack is intended for use in treatment of the metacarpal, phalange, clavicle, radius, ulna, distal radius, olecranon and fibula. It is also indicated for the treatment of impending and actual pathological fractures of the humerus from metastatic bone disease.

For more detailed procedural information including Warnings, Cautions, Risks & Contraindications, please visit www.illuminOss.com for the correct surgical technique guide.

Section iconCompany Overview

Phone number
SIC Code
3841 - Surgical and Medical Instruments and Apparatus
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $5M

    IlluminOss Medical has raised a total of $5M of funding over 7 rounds. Their latest funding round was raised on Feb 05, 2016 in the amount of $5M.

  • $1M$10M

    IlluminOss Medical's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5M

    IlluminOss Medical has raised a total of $5M of funding over 7 rounds. Their latest funding round was raised on Feb 05, 2016 in the amount of $5M.

  • $1M$10M

    IlluminOss Medical's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.